The speakers will take you on a journey from discovering novel biomarkers to implementing them in clinical trials and clinical practice. Join us for a webinar focused on tissue remodeling, inflammation, and biomarkers for pulmonary diseases.

Watch the webinar

This webinar will provide a unique opportunity to hear from experts in the field and gain valuable insights into the latest advancements in tumor fibrosis research. Join us to learn about cutting-edge approaches to developing new therapeutic targets, and the use of biomarkers for patient stratification and evaluating treatment efficacy.

Watch the webinar

In this edition of the ECM Pharmacology Symposium Series, we will address the mechanisms of neutrophil activity in chronic diseases, in particular on fibro-inflammation in inflammatory bowel diseases, focusing in particular on fibro-inflammation and mucosal damage.

Watch the webinar

In this installation of the ECM Pharmacology Symposium series, Dr. Adam Croft discusses fibroblast activation in arthritis. Dr. Dana Orange presents on PRIME cells in rheumatoid arthritis flares, and Dr. Anne Bay-Jensen shares insights on the identification of fibrotic and fibrolytic endotypes in rheumatic disease cohorts.

Watch the webinar

In this webinar, we will talk about ECM remodeling as the common denominator of all fibro-inflammatory disorders. We will also discuss how ECM turnover may lead to better insight into disease mechanisms and a better biological understanding of individual patients and how we can best use this to guide drug development.

Finally, we delve into endotrophin, a collagen hormone in multi-organ diseases, and endotrophin in HFpEF, a potentially treatable high-risk endotype.

Watch the webinar

In this webinar, we explain how a simple blood sample can be quantified by the Protein Fingerprint Technology and be used as a sophisticated biomarker tool for tailoring treatment solutions, predicting and monitoring disease progression and treatment response.

Part 1 of the ECM Symposium 2021 Webinar series. 

Watch the webinar

In this webinar, we explain how we can identify the right efficacy in biomarker-driven clinical trials and research.

Part 2 of the ECM Symposium 2021 Webinar series. 

Watch the webinar

In this webinar, we take a look beyond the interstitial matrix and take a deep dive into some respiratory diseases, such as Idiopathic Pulmonary Fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD).

Part 3 of the ECM Symposium 2021 Webinar series. 

Watch the webinar

In this webinar, we investigate the role of extracellular matrix remodeling in cardiovascular diseases, from atherosclerosis to Heart Failure with Preserved Ejection Fraction (HFpEF)

Part 4 of the ECM Symposium 2021 Webinar series. 

Watch the webinar

In this webinar, we explain the role of blood-based tissue profiling in immunology through some arthritis examples.

Part 5 of the ECM Symposium 2021 Webinar series. 

Watch the webinar

In this webinar, we investigate how tumor fibrosis deactivates the immune system.

Part 6 of the ECM Symposium 2021 Webinar series.

Watch the webinar

In this webinar, we take a look at how the turnover of the interstitial matrix can predict adverse outcomes in Kidney Fibrosis.

Part 7 of the ECM Symposium 2021 Webinar series. 

Watch the webinar

In this webinar, we explain how it's possible to identify early response and fistulizing and fibrostenotic endotypes in Inflammatory Bowel Disease.

Part 8 of the ECM Symposium 2021 Webinar series. 

Watch the webinar

In this webinar, we explore the regulatory landscape around CLSI standards and In Vitro Diagnostic (IVD) product approvals.

Part 9 of the ECM Symposium 2021 Webinar series. 

Watch the webinar

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.